Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	10.72	345.07	311.67
Graham Fair Price	-3.71	4.43	4.60
PEG	120.60	-12.50	5.67
Price/Book	-20.21	6.72	8.43
Price/Cash Flow	-53.32	111.75	239.42
Prices/Earnings	-5.46	89.28	94.44
Price/Sales	-19.44	35.58	44.17
Price/FCF	-53.32	111.75	239.42
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-2.11	0.80	0.81
Operating Margin	-37.94	0.06	0.10
ROA	-21.82	0.01	0.01
ROE	0.02	0.02	-15.60
ROIC	0.02	0.01	-22.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.06	-0.02	-228.52
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.01	-0.35	2657.86
EPS QOQ	0.17	-0.07	-57.14
FCF QOQ	0.97	0.80	-17.81
Revenue QOQ	0.04	0.04	13.27
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.43	0.00	inf
Days Sales Outstanding (DSO)	89.15	145.00	62.64
Inventory Turnover	0.75	0.00	inf
Debt/Capitalization	0.04	0.03	-10.76
Quick Ratio	1.19	1.15	-3.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6.49	6.80	4.81
Cash	2.65	2.82	6.42
Capex	-0.03	-0.04	-24.83
Free Cash Flow	0.23	0.41	79.18
Revenue	1.24	1.29	3.82
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.34	1.20	-10.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.32	-19.06	-33.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating